Decreased activity of basal ganglia is the main cause of abnormal muscle constrictions in dystonia

December 17, 2008

Dystonia is a neurological disorder characterized by involuntary abnormal muscle constrictions. More than 300,000 people in North America are affected, but the mechanism of abnormal muscle constrictions has not been well understood. Here, Japanese research team led by Prof Atsushi Nambu and Dr Satomi Chiken of National Institute for Physiological Sciences (NIPS) in Japan, with Dr. Pullanipally Shashidharan of Mt Sinai School of Medicine in USA, has found that the decreased activity of the basal ganglia, a part of the brain structure, is the main cause of abnormal muscle constrictions of dystonia using a mouse model. They report their findings in Journal of Neuroscience, on Dec 17, 2008.

They investigated neuronal activity in the basal ganglia of a dystonia mouse model, which was generated by transferring human dystonia genes, in awake state. Basal ganglia send inhibitory signals to the motor cortex and tune optimal movement in normal state. However, in the dystonia mouse model, the neuronal activity is decreased so that basal ganglia cannot inhibit motor cortical activity related to unnecessary movements. The research team has concluded that this is the main cause of involuntary abnormal muscle constrictions in dystonia patients.

"Now we understand the mechanism of abnormal muscle constrictions in dystonia. If we can artificially increase basal ganglia activity, abnormal muscle constrictions in dystonia patients could be well controlled", said Prof Nambu and Dr Chiken.
-end-


National Institute for Physiological Sciences

Related Dystonia Articles from Brightsurf:

Researchers find brain cell that triggers tremor and how to control it
Researchers have improved our understanding of how tremor -- the most common movement disorder -- happens, opening the possibility of novel therapies for this condition.

An oral splint that can reduce Tourette syndrome tics
Osaka University researchers developed a new device that ameliorates the characteristic vocal and motor tics of Tourette syndrome.

Mayo Clinic researchers uncover methods to quantify the yips and golfer's cramp
Almost every golfer knows the feeling. Minutes after a picture-perfect drive down the fairway, a cascade of inexplicable missed putts leads to a disappointing triple bogey.

Lightning carries potential danger to people with deep brain stimulators
Patients receiving deep brain stimulation are warned that their neurostimulators may dysfunction when confronted by electromagnetic fields generated by particular electrical devices found at work, home, and in the hospital.

Mass. General-led team identifies genetic defect that may cause rare movement disorder
A Massachusetts General Hospital-led research team has found that a defect in transcription of the TAF1 gene may be the cause of X-linked dystonia parkinsonism (XDP), a rare and severe neurodegenerative disease.

Deep brain stimulation: Improving outcomes in the treatment of movement disorders
For the first time, researchers from Charité have shown that, in patients with a type of movement disorder known as dystonia, a particular pattern of brain activity is linked to both the severity of symptoms and the clinical outcomes achieved through deep brain stimulation.

New botulinum neurotoxin discovered -- potential to treat a number of medical conditions
The first new botulinum neurotoxin in almost half a century has been discovered by researchers at Stockholm University and Harvard Medical School.

Review: Insomnia medication may wake up some patients from vegetative state
A systematic review of zolpidem for noninsomnia neurological disorders, including movement disorders and disorders of consciousness, finds reason for additional research.

Cause of an inherited neurological disorder discovered
Researchers at the University of Liverpool have identified the basis for how a single gene mutation can cause a rare neurological movement disorder known as dystonia.

Remarkable recovery in patients diagnosed with newly defined movement disorder
A team of researchers from UCL Great Ormond Street Institute of Child Health, University of Cambridge and the NIHR Rare Disease Bioresource have identified mutations in the KMT2B gene in 28 patients with dystonia.

Read More: Dystonia News and Dystonia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.